Skip to main content
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. — Investor Relations & Filings

Ticker · GPCR ISIN · US86366E1064 US Manufacturing
Filings indexed 223 across all filing types
Latest filing 2025-06-25 Regulatory Filings
Country US United States of America
Listing US GPCR

About Structure Therapeutics Inc.

https://structuretx.com/

Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company that utilizes a proprietary structure-based drug design platform to discover and develop novel oral small molecule therapeutics. The company focuses on creating more accessible treatments for a range of chronic diseases by targeting G protein-coupled receptors (GPCRs), a well-validated class of drug targets. Its clinical pipeline includes drug candidates for cardiometabolic conditions, such as obesity and type 2 diabetes, as well as pulmonary diseases.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2025-06-25 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-15 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-13 English
10-Q
Interim / Quarterly Report Q1 2025
2025-05-08 English
FORM 8-K
Regulatory Filings
2025-05-08 English
ARS
Annual Report
2025-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.